Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carlyle Group
Biotech
Abingworth channels $356M into late-stage clinical programs
Investor Abingworth has closed a $356 million fund aimed at supporting biopharmas with late-stage programs.
Gabrielle Masson
Oct 30, 2023 10:55am
Carlyle Group in talks to close $7B Medtronic spinoff deal
Oct 2, 2023 10:27am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
Investment firm Carlyle snaps up majority stake in TriNetX
Sep 22, 2020 8:05am
Singapore, UAE government funds’ new investments put PPD at $9B
Apr 28, 2017 9:08am